Skip to content
★ Sign in to follow
JG

Jonathan Glenn

CEO
Consort Medical PLC
Total declarations
37
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€620k

Latest filing published 06 Feb 2020 for Consort Medical PLC.

Filing timeline

BuySale
Jonathan Glenn

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

Jonathan Glenn: trading record in brief

All filings by Jonathan Glenn on record concern Consort Medical PLC. Over a trading history stretching from 21 October 2016 to 4 February 2020, the count stands at 37 filings.

No open-market purchase appears, only 1 sale worth €620k. Besides market trades, the filings include 33 share grants and 3 option exercises.

On 6 February 2020 came the latest disclosure, a share grant in Consort Medical PLC. Filings reach the RNS (LSE) feed a median of 2 days after the trade. For comparison, UK MAR gives managers three business days to notify a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to Jonathan Glenn

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations37 total
  • ◆
    CEOExecutivesConsort Medical PLC
    0FCA-NSM
    432,399 sharesExercise of options: Off market Sale of share under offer: London Stock ExchangeISIN GB0000946276FCA-NSM:LSE20200206163125_3486886_20200331164939827_5995-0
  • ◆
    CEOExecutivesConsort Medical PLC
    148 GBP22FCA-NSM
    14 shares@ £10.54790.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191211093201_14344236_20200326185105895_19266-0
  • ◆
    CEOExecutivesConsort Medical PLC
    155 GBP22FCA-NSM
    21 shares@ £7.360.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191111112348_14302817_20200326185148287_22020-0
  • ◆
    CEOExecutivesConsort Medical PLC
    1,215 GBP22FCA-NSM
    164 shares@ £7.4080.1% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191101070006_14290011_20200326185148836_32421-0
  • ◆
    CEOExecutivesConsort Medical PLC
    146 GBP27FCA-NSM
    20 shares@ £7.29448.6% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191009101440_14259719_20200326185154548_26986-0
  • ◆
    CEOExecutivesConsort Medical PLC
    155 GBP27FCA-NSM
    20 shares@ £7.73151.4% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20190913090323_14225783_20200326185204416_24361-0
  • ◆
    CEOExecutivesConsort Medical PLC
    0FCA-NSM
    69,438 sharesOff market transactionISIN GB0000946276FCA-NSM:LSE20190829120613_14206597_20200326185055315_3003-0
  • ◆
    CEOExecutivesConsort Medical PLC
    0FCA-NSM
    46,625 sharesOff market transactionISIN GB0000946276FCA-NSM:LSE20190816110857_14192123_20200326185057267_20340
  • ◆
    CEOExecutivesConsort Medical PLC
    150 GBP22FCA-NSM
    20 shares@ £7.520.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20190812095436_14185124_20200326185058006_28632-0
  • ◆
    CFOExecutivesConsort Medical PLC
    26,989 GBP19FCA-NSM
    3,487 shares@ £7.742.2% of flowOutside of a trading venueISIN GB0000946276FCA-NSM:LSE20190725084415_14162891_20200326185123330_8757-0
  • ◆
    CFOExecutivesConsort Medical PLC
    0FCA-NSM
    37,007 sharesOff market transactionISIN GB0000946276FCA-NSM:LSE20190725070023_14162314_20200326185123352_9234
  • ◆
    CEOExecutivesConsort Medical PLC
    152 GBP22FCA-NSM
    21 shares@ £7.25710.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20181211091157_13899103_20200330111408224_9401-0
  • ◆
    CEOExecutivesConsort Medical PLC
    145 GBP22FCA-NSM
    13 shares@ £11.19080.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20181108154931_13860676_20200330111438836_22440-0
  • ◆
    CEOExecutivesConsort Medical PLC
    1,147 GBP22FCA-NSM
    101 shares@ £11.360.1% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20181031111751_13849534_20200330111442171_586-0
  • ◆
    CEOExecutivesConsort Medical PLC
    160 GBP22FCA-NSM
    14 shares@ £11.42570.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20181010142409_13823796_20200330111443439_18950-0
  • ◆
    CFOExecutivesConsort Medical PLC
    26,994 GBP19FCA-NSM
    2,242 shares@ £12.042.3% of flowOutside of a trading venueISIN GB0000946276FCA-NSM:LSE20181002125753_13813374_20200330111443779_26183-0
  • ◆
    CEOExecutivesConsort Medical PLC
    146 GBP22FCA-NSM
    12 shares@ £12.200.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20180910070007_13783863_20200330111447118_17626-0
  • ◇
    CEOExecutivesConsort Medical PLC
    8,998 GBP22FCA-NSM
    991 shares@ £9.080.8% of flowOutside a trading venueISIN GB0000946276FCA-NSM:LSE20180906154738_13781961_20200330111447187_19053
  • ◇
    CEOExecutivesConsort Medical PLC
    0FCA-NSM
    48,449 shares098.2% of flowOff market transactionISIN GB0000946276FCA-NSM:LSE20180822172140_13765130_20200330111401061_6520
  • ▼
    CEOExecutivesConsort Medical PLC
    556,195 GBP0FCA-NSM
    48,449 shares@ £11.48Off market transactionISIN GB0000946276FCA-NSM:LSE20180822172140_13765130_20200330111401061_6520-1
  • ◆
    CEOExecutivesConsort Medical PLC
    149 GBP22FCA-NSM
    13 shares@ £11.460.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20180809070014_13749058_20200330111404481_16786-0
  • ◆
    CEOExecutivesConsort Medical PLC
    153 GBP22FCA-NSM
    13 shares@ £11.760.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20180711161657_13714481_20200330111420626_17076-0
  • ◆
    Managing Director Bespak DivisionExecutivesConsort Medical PLC
    9,745 GBP22FCA-NSM
    79,875 shares@ £0.1220.9% of flowOff market transactionISIN GB0000946276FCA-NSM:LSE20180620162200_13687587_20200330111423611_9524
  • ◆
    CEOExecutivesConsort Medical PLC
    153 GBP22FCA-NSM
    13 shares@ £11.75620.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20171211084643_13460437_20200330131507515_7690-0
  • ◆
    CEOExecutivesConsort Medical PLC
    151 GBP22FCA-NSM
    14 shares@ £10.790.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20171109112351_13426299_20200330131534313_7989-0

25 of 37 declarations